Alzheimer’s drugs

26th April 2011 by Louise Hudman

Some new alzheimers drugs

  • Donepazine, galantamine and rivastigmine can now be used in mild, as well as in moderate disease.
  • Memantine can be used if someone is intolerant to or has contraindications to the other drugs and can also be used in severe disease.
  • Initiation is still by specialists but follow-up can be done by others where local protocols are in place. Standard cognitive assessment tools should be used where possible for follow-up and drugs only continued if there is ongoing benefit.

Join

Join to view the rest of this content, as well as access all the benefits of joining NASGP.

Join

Login

Already a member? Login to view this content.

Login

"I’m loving LocumDeck, it’s a great piece of software."

Dr David Williams

Dr David Williams

See the full list of features within our NASGP membership plans

Membership